Personalized Therapeutic Strategies in the Management of Osteoporosis in Patients with Autoantibody-Positive Rheumatoid Arthritis.

D'Onofrio, Bernardo; di Lernia, Michele; De Stefano, Ludovico; Bugatti, Serena; Montecucco, Carlomaurizio; Bogliolo, Laura

D'Onofrio, Bernardo; di Lernia, Michele; De Stefano, Ludovico; Bugatti, Serena; Montecucco, Carlomaurizio; Bogliolo, Laura.

Afiliação

D'Onofrio B; Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, 27100 Pavia, Italy.
di Lernia M; Department of Internal Medicine and Therapeutics, University of Pavia, 27100 Pavia, Italy.
De Stefano L; Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, 27100 Pavia, Italy.
Bugatti S; Department of Internal Medicine and Therapeutics, University of Pavia, 27100 Pavia, Italy.
Montecucco C; Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, 27100 Pavia, Italy.
Bogliolo L; Department of Internal Medicine and Therapeutics, University of Pavia, 27100 Pavia, Italy.

J Clin Med ; 11(9)2022 Apr 22.

Article em En | MEDLINE | ID: mdl-35566466

Palavras-chave

anti-citrullinated antibodies; denosumab; osteoporosis; rheumatoid arthritis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: J Clin Med Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google